Intended for healthcare professionals

Rapid response to:

News

Covid-19: concerns grow over inflammatory syndrome emerging in children

BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1710 (Published 28 April 2020) Cite this as: BMJ 2020;369:m1710

Read our latest coverage of the coronavirus pandemic

Rapid Response:

Re: Covid-19: concerns grow over inflammatory syndrome emerging in children

Dear Editor

The Bexsero Men B vaccine, in use in the UK since 2015, could predispose children in this country towards Kawasaki disease. According to the package insert the vaccine may result in Kawasaki disease in one in one thousand doses and British infants receive three [1,2,3]. So far there seem to be no reports of this COVID-19 complication in other countries [4].

[1] Bexsero PIL, https://www.medicines.org.uk/emc/files/pil.5168.pdf

[2] John Stone, 'An argument already lost by default?', 22 November 2019, https://www.bmj.com/content/367/bmj.l6447/rr

[3] John Stone, 'Re:An argument already lost by default?', 23 November 2019, https://www.bmj.com/content/367/bmj.l6447/rr-2

[4] Elisabeth Mahase, 'Covid-19: concerns grow over inflammatory syndrome emerging in children',
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1710 (Published 28 April 2020)

Competing interests: AgeofAutism.com, an on-line daily journal, concerns itself with the potential environmental sources for the proliferation of autism, neurological impairment, immune dysfunction and chronic disease. I receive no payment as UK Editor

28 April 2020
John Stone
UK Editor
AgeofAutism.com
London N22